Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 519

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study

Fava, Maurizio, Rush, A.John, Trivedi, Madhukar H, Nierenberg, Andrew A, Thase, Michael E, Sackeim, Harold A, Quitkin, Frederic M, Wisniewski, Steven, Lavori, Philip W, Rosenbaum, Jerrold F, Kupfer, David J, for the STAR∗D Investigators Group·2003·Psychiatric Clinics of North America
DOI 10.1016/s0193-953x(02)00107-7
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0193-953x(02)00107-7

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 130

  1. Frank, 1993, Efficacy of treatments for major depression, Psychopharmacol Bull, 29, 457
  2. Fava, 1996, Definition and epidemiology of treatment-resistant depression, Psychiatr Clin North Am, 19, 179, 10.1016/S0193-953X(05)70283-5 · DOI · Paper page
  3. Agosti, 1999, Predictors of persistent social impairment among recovered depressed outpatients, J Affect Disord, 55, 215, 10.1016/S0165-0327(98)00200-6 · DOI
  4. Depression Guideline Panel. Clinical practice guideline. Number 5. Depression in primary care, vol. 1. Detection and diagnosis. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93–0550; 1993.
  5. Mueller, 1996, Recovery, chronicity, and levels of psychopathology in major depression, Psychiatr Clin North Am, 19, 85, 10.1016/S0193-953X(05)70275-6 · DOI
  6. Keller, 1995, Results of the DSM-IV Mood Disorders Field Trial, Am J Psychiatry, 152, 843, 10.1176/ajp.152.6.843 · DOI · Paper page
  7. Judd, 1998, A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders, Arch Gen Psychiatry, 55, 694, 10.1001/archpsyc.55.8.694 · DOI · Paper page
  8. Thase, 1994, Refractory depression: relevance of psychosocial factors and therapies, Psychiatr Ann, 24, 232, 10.3928/0048-5713-19940501-09 · DOI
  9. Depression Guideline Panel. Clinical practice guideline. Number 5. Depression in primary care, vol. 2. Treatment of major depression. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93–0551;1993.
  10. Murray, 1996, Evidence-based health policy: lessons from the Global Burden of Disease Study, Science, 274, 740, 10.1126/science.274.5288.740 · DOI · Paper page
  11. Greenberg, 1993, The economic burden of depression in 1990, J Clin Psychiatry, 54, 405
  12. Simon, 1998, Health care costs of primary care patients with recognized depression, Arch Gen Psychiatry, 52, 850, 10.1001/archpsyc.1995.03950220060012 · DOI · Paper page
  13. Judd, 1997, The clinical course of unipolar major depressive disorders, Arch Gen Psychiatry, 54, 989, 10.1001/archpsyc.1997.01830230015002 · DOI · Paper page
  14. Miller, 1998, The treatment of chronic depression,, J Clin Psychiatry, 59, 608, 10.4088/JCP.v59n1108 · DOI · Paper page
  15. Rush, 1995, Treating depression to remission, Psychiatr Ann, 25, 704, 10.3928/0048-5713-19951201-03 · DOI
  16. McCombs, 1993, Pharmacy-enforced outpatient drug treatment protocols: a case study of Medical restrictions for cefaclor, Ann Pharmacother, 27, 155, 10.1177/106002809302700203 · DOI
  17. Jarrett, 1994, Short-term psychotherapy of depressive disorders: current status and future directions, Psychiatry: Interpers Biol Process, 57, 115, 10.1080/00332747.1994.11024675 · DOI
  18. Hamilton, 1967, Development of a rating scale for primary depressive illness, Br J Soc Clin Psychol, 6, 278, 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
  19. Riso, 1997, A prospective test of criteria for response, remission, relapse, recovery, and recurrence in patients treated with cognitive behavior therapy, J Affect Disord, 43, 131, 10.1016/S0165-0327(96)01420-6 · DOI
  20. Rush, 1999, Psychotherapies for depressive disorders, vol. 1, 161, 10.1002/0470842342.ch3 · DOI
  21. Akiskal, 1981, Subaffective disorders: dysthymic, cyclothymic, and bipolar II disorders in the “borderline” realm, Psychiatr Clin North Am, 4, 25, 10.1016/S0193-953X(18)30935-3 · DOI · Paper page
  22. Howland, 1993, General health, health care utilization, and medical comorbidity in dysthymia, Int J Psychiatr Med, 23, 211, 10.2190/AXCU-P704-23XQ-CQTR · DOI
  23. American Psychiatric Association, 1993, Practice guideline for major depressive disorder in adults, Am J Psychiatry, 150, 1
  24. American Psychiatric Association, 2000, Practice guideline for the treatment of patients with major depressive disorder, Am J Psychiatry, 157, 1
  25. Gilbert, 1998, Texas Medication Algorithm Project: definitions, rationale and methods to develop medication algorithms, J Clin Psychiatry, 59, 345, 10.4088/JCP.v59n0702 · DOI · Paper page
  26. Rush, 1995, From scientific knowledge to the clinical practice of psychopharmacology: Can the gap be bridged?, Psychopharmacol Bull, 31, 7
  27. Fava, 1994, Continuation and maintenance treatments of major depressive disorder, Psychiatr Ann, 24, 281, 10.3928/0048-5713-19940601-07 · DOI
  28. Keller, 1998, The treatment of chronic depression,, J Clin Psychiatry, 59, 598, 10.4088/JCP.v59n1107 · DOI
  29. Rosenbaum, 2001, Treatment-resistant mood disorders, vol. 2, 1307
  30. Byrne, 1997, Psychiatrists' responses to failure of maintenance therapy with antidepressants, Psychiatr Serv, 48, 835, 10.1176/ps.48.6.835 · DOI
  31. Frank, 1990, Three-year outcomes for maintenance therapies in recurrent depression, Arch Gen Psychiatry, 47, 1093, 10.1001/archpsyc.1990.01810240013002 · DOI · Paper page
  32. Frank, 1992, Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression, Psychopharmacol Bull, 28, 231
  33. Thase, 1997, When at first you don't succeed: sequential strategies for antidepressant nonresponders, J Clin Psychiatry, 58, 23
  34. Bridges, 1983, …and a small dose of an antidepressant might help, Br J Psychiatry, 142, 626, 10.1192/bjp.142.6.626 · DOI
  35. Brugha, 1992, Antidepressants may not assist recovery in practice: a naturalistic prospective study, Acta Psychiatr Scand, 86, 5, 10.1111/j.1600-0447.1992.tb03218.x · DOI
  36. Fauman, 1980, Tricyclic antidepressant prescription by general hospital physicians, Am J Psychiatry, 237, 490
  37. Johnson, 1974, A study of the use of antidepressant medication in general practice, Br J Psychiatry, 125, 186, 10.1192/bjp.125.2.186 · DOI
  38. Keller, 1982, Treatment received by depressed patients, JAMA, 248, 1848, 10.1001/jama.1982.03330150034019 · DOI · Paper page
  39. Ketai, 1976, Family practitioners knowledge about treatment of depressive illness, JAMA, 235, 2600, 10.1001/jama.1976.03260500016018 · DOI
  40. Kotin, 1973, Drug treatment of depressed patients referred for hospitalization, Am J Psychiatry, 130, 1139, 10.1176/ajp.130.10.1139 · DOI
  41. Nierenberg, 1990, After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression, J Affect Disord, 18, 167, 10.1016/0165-0327(90)90033-5 · DOI
  42. Ravaris, 1976, A multiple dose controlled study of phenelzine in depression-anxiety states, Arch Gen Psychiatry, 33, 347, 10.1001/archpsyc.1976.01770030057008 · DOI
  43. Simpson, 1976, Two dosages of imipramine in hospitalized endogenous and neurotic depressives, Arch Gen Psychiatry, 33, 1093, 10.1001/archpsyc.1976.01770090083008 · DOI
  44. Tyrer, 1980, Clinical and pharmacokinetic factors affecting response to phenelzine, Br J Psychiatry, 136, 359, 10.1192/bjp.136.4.359 · DOI
  45. Watt, 1972, Metabolism, anticholinergic effects and therapeutic effects on outcome of desmethylimipramine in depressive illness, Psychol Med, 2, 397, 10.1017/S0033291700045219 · DOI
  46. Dornseif, 1989, Effect of dose escalation after low-dose fluoxetine therapy, Psychopharmacol Bull, 25, 71
  47. Preskorn, 1995, Sertraline 50 mg daily; the optimal dose in the treatment of depression, Int Clin Psychopharmacol, 10, 129, 10.1097/00004850-199510030-00001 · DOI
  48. Schweitzer, 1990, What constitutes an adequate antidepressant trial for fluoxetine?, J Clin Psychiatry, 51, 8
  49. Fava, 1992, High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine, J Affect Disord, 25, 229, 10.1016/0165-0327(92)90080-P · DOI
  50. Fava, 1994, Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study, Am J Psychiatry, 151, 1372, 10.1176/ajp.151.9.1372 · DOI
  51. Kelsey, 1996, Dose-response relationship with venlafaxine, J Clin Psychopharmacol, 16, 21S, 10.1097/00004714-199606002-00005 · DOI
  52. Fava, 2001, Augmentation and combination strategies in treatment-resistant depression, J Clin Psychiatry, 62, 4
  53. Ontiveros, 1991, Refractory depression: the addition of lithium to fluoxetine or desipramine, Acta Psychiatr Scand, 83, 188, 10.1111/j.1600-0447.1991.tb05522.x · DOI
  54. Baumann, 1996, A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation, J Clin Psychopharmacol, 16, 307, 10.1097/00004714-199608000-00006 · DOI
  55. de Montigny, 1983, Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression: correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system, Arch Gen Psychiatry, 40, 1327, 10.1001/archpsyc.1983.01790110069012 · DOI · Paper page
  56. Heninger, 1983, Lithium carbonate augmentation of antidepressant action: an effective prescription for treatment refractory depression, Arch Gen Psychiatry, 40, 1335, 10.1001/archpsyc.1983.01790110077013 · DOI · Paper page
  57. Joffe, 1993, An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression, J Clin Psychiatry, 54, 269
  58. Kantor, 1986, The benefit of lithium carbonate adjunct in refractory depression: fact or fiction?, Can J Psychiatry, 31, 416, 10.1177/070674378603100506 · DOI
  59. Katona, 1995, Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine, Br J Psychiatry, 166, 80, 10.1192/bjp.166.1.80 · DOI
  60. Schopf, 1989, Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition, Pharmacopsychiatry, 22, 183, 10.1055/s-2007-1014603 · DOI
  61. Stein, 1993, Lithium augmentation therapy in tricyclic-resistant depression: a controlled trial using lithium in low and normal doses, Br J Psychiatry, 162, 634, 10.1192/bjp.162.5.634 · DOI
  62. Zusky, 1988, Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study, J Clin Psychopharmacol, 8, 120, 10.1097/00004714-198804000-00007 · DOI
  63. Prange, 1996, Novel uses of thyroid hormone in patients with affective disorders, Thyroid, 6, 537, 10.1089/thy.1996.6.537 · DOI
  64. Aronson, 1996, Triiodothyronine augmentation in the treatment of refractory depression: a meta-analysis, Arch Gen Psychiatry, 53, 842, 10.1001/archpsyc.1996.01830090090013 · DOI · Paper page
  65. Bouwer, 1997, Buspirone is an effective augmenting agent of serotonin selective reuptake inhibitors in severe treatment-refractory depression, South Afr Med J, 87, 534
  66. Dimitriou, 1998, Buspirone augmentation of antidepressant therapy, J Clin Psychopharmacol, 18, 465, 10.1097/00004714-199812000-00009 · DOI
  67. Jacobsen, 1991, A possible augmentation of antidepressant response by buspirone, J Clin Psychiatry, 52, 217
  68. Landen, 1998, A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression, J Clin Psychiatry, 59, 664, 10.4088/JCP.v59n1204 · DOI
  69. Appelberg, 2001, Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study, J Clin Psychiatry, 62, 448, 10.4088/JCP.v62n0608 · DOI
  70. Fredman, 2000, Partial response, non-response, and relapse on SSRIs in major depression: a survey of current “next-step” practices, J Clin Psychiatry, 61, 403, 10.4088/JCP.v61n0602 · DOI
  71. Marshall, 1996, Paroxetine/bupropion combination treatment for refractory depression, J Clin Psychopharmacol, 16, 80, 10.1097/00004714-199602000-00016 · DOI
  72. Marshall, 1995, Bupropion and sertraline combination treatment in refractory depression, J Psychopharmacol, 9, 284, 10.1177/026988119500900313 · DOI
  73. Spier, 1998, Use of bupropion with SRIs and venlafaxine, Depress Anxiety, 7, 73, 10.1002/(SICI)1520-6394(1998)7:2<73::AID-DA4>3.0.CO;2-6 · DOI
  74. Carpenter, 1999, Mirtazapine augmentation in the treatment of refractory depression, J Clin Psychiatry, 60, 45, 10.4088/JCP.v60n0110 · DOI
  75. Debonnel G, Gobbi G, Turcotte J, et al. The α2 antagonist mirtazapine combined with the SSRI paroxetine induces a greater antidepressant response: a double-blind controlled study. Presented at the 39th Annual Meeting of the American College of Neuropsychopharmacology. San Juan, Puerto Rico, December 10–14, 2000. · DOI
  76. Fava, 1998, Prevention of recurrent depression with cognitive therapy: preliminary findings, Arch Gen Psychiatry, 55, 816, 10.1001/archpsyc.55.9.816 · DOI · Paper page
  77. Charney, 1998, Monoamine dysfunction and the pathophysiology and treatment of depression, J Clin Psychiatry, 59, 11
  78. van Praag, 1990, Monoamines and abnormal behaviour: a multi-aminergic perspective, Br J Psychiatry, 157, 723, 10.1192/bjp.157.5.723 · DOI
  79. Fulgum, 1996, Screening and treating depressed patients: a comparison of two controlled citalopram trials across treatment settings: hospitalized patients versus patients treated by their family doctors, Acta Psychiatr Scand, 94, 18, 10.1111/j.1600-0447.1996.tb09819.x · DOI
  80. McGrath, 1994, Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant, J Clin Psychiatry, 55, 336
  81. McGrath, 1993, A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression, Am J Psychiatry, 150, 118, 10.1176/ajp.150.1.118 · DOI
  82. Thase, 1992, Treatment of imipramine-resistant recurrent depression,, Am J Psychiatry, 149, 195
  83. Beasley, 1990, Fluoxetine in tricyclic refractory major depressive disorder, J Affect Disord, 20, 193, 10.1016/0165-0327(90)90144-W · DOI
  84. Fava, 2000, Management of nonresponse and intolerance: switching strategies, J Clin Psychiatry, 61, 10
  85. Joffe, 1996, Response to an open trial of a second SSRI in major depression, J Clin Psychiatry, 57, 114
  86. Thase, 1997, Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline, J Clin Psychiatry, 58, 16, 10.4088/JCP.v58n0103 · DOI
  87. Thase, 2001, Citalopram treatment of fluoxetine nonresponders, J Clin Psychiatry, 62, 683, 10.4088/JCP.v62n0904 · DOI
  88. Thase, 2002, Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression, Arch Gen Psychiatry, 59, 233, 10.1001/archpsyc.59.3.233 · DOI
  89. de Montigny, 1999, Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial, J Clin Psychopharmacol, 19, 401, 10.1097/00004714-199910000-00003 · DOI
  90. Fava, 2001, Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial, J Clin Psychiatry, 62, 413, 10.4088/JCP.v62n0603 · DOI
  91. Rush, 1999, Implementing guidelines and systems of care: experiences with the Texas Medication Algorithm Project (TMAP), J Pract Psychiatry Behav Health, 5, 75, 10.1097/00131746-199903000-00002 · DOI
  92. Kobak, 1999, Computerized assessment of depression and anxiety over the telephone using Interactive Voice Response, MD Comput, 16, 61
  93. Basco, 1995, Compliance with pharmacotherapy in mood disorders, Psychiatr Ann, 25, 269, 10.3928/0048-5713-19950501-03 · DOI
  94. Paykel, 1999, Prevention of relapse in residual depression by cognitive therapy: a controlled trial, Arch Gen Psychiatry, 56, 829, 10.1001/archpsyc.56.9.829 · DOI · Paper page
  95. Williams, 1988, A structured interview guide for the Hamilton Depression Rating Scale, Arch Gen Psychiatry, 45, 742, 10.1001/archpsyc.1988.01800320058007 · DOI
  96. Rush, 1986, The Inventory for Depressive Symptomatology (IDS): preliminary findings, Psychiatry Res, 18, 65, 10.1016/0165-1781(86)90060-0 · DOI · Paper page
  97. Reilly, 1993, The validity and reproducibility of a work productivity and activity impairment instrument, Pharmacoeconomics, 4, 353, 10.2165/00019053-199304050-00006 · DOI · Paper page
  98. Endicott, 1993, Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q): a new measure, Psychopharmacol Bull, 29, 321
  99. Clark, 1996, Measuring hospital use without claims: a comparison of patient and provider reports, Health Serv Res, 31, 153
  100. Dresser, 1997, Clinical quality measurement: comparing chart review and automated methodologies, Med Care, 35, 539, 10.1097/00005650-199706000-00001 · DOI
  101. Kashner, 1998, Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs, Med Care, 36, 1324, 10.1097/00005650-199809000-00005 · DOI · Paper page
  102. Kashner, 1992, An analysis of panel data: the impact of a psychiatric consultation letter on the expenditures and outcomes of care for patients with somatization disorder, Med Care, 30, 811, 10.1097/00005650-199209000-00005 · DOI
  103. Magaziner, 1988, Patient-proxy response comparability on measures of patient health and functional status, J Clin Epidemiol, 41, 1065, 10.1016/0895-4356(88)90076-5 · DOI · Paper page
  104. Quam, 1993, Using claims data for epidemiologic research: the concordance of claim-based criteria with the medical record and patient survey for identifying a hypertensive population, Med Care, 31, 498, 10.1097/00005650-199306000-00003 · DOI
  105. Kashner, 1999, Measuring costs of guideline-drive mental health care: The Texas Medication Algorithm Project, J Ment Health Policy Econ, 2, 111, 10.1002/(SICI)1099-176X(199909)2:3<111::AID-MHP52>3.0.CO;2-M · DOI
  106. Rush, 1999, Medication treatment of the severely and persistently mentally ill: The Texas Medication Algorithm Project, J Clin Psychiatry, 60, 142, 10.4088/JCP.v60n0503 · DOI
  107. Lavori, 2001, Strengthening clinical effectiveness trials: equipoise-stratified randomization, Biol Psychiatry, 50, 792, 10.1016/S0006-3223(01)01223-9 · DOI
  108. Eisenthal, 1979, “Adherence” and the negotiated approach to patienthood, Arch Gen Psychiatry, 36, 393, 10.1001/archpsyc.1979.01780040035003 · DOI
  109. Frank, 1995, Alliance not compliance: a philosophy of outpatient care, J Clin Psychiatry, 56, 11
  110. Ezra, 1997, An analysis of treatment preferences in patients of a late life depression clinic, Dissertation Abstracts International: Section B: The Sciences and Engineering, 57, 5324
  111. Nierenberg, 1997, Declaration of treatment failures, 17, 10.1159/000061672 · DOI
  112. Rush, 2001, Strategies and tactics in the treatment of depression, vol. 2, 1417
  113. Meterissian, 1989, Comparative studies on the efficacy of psychotherapy, pharmacotherapy, and their combination in depression: was adequate pharmacotherapy provided?, J Clin Psychopharmacol, 9, 334, 10.1097/00004714-198910000-00004 · DOI
  114. Quitkin, 1984, Duration of antidepressant drug treatment, what is an adequate trial?, Arch Gen Psychiatry, 41, 238, 10.1001/archpsyc.1984.01790140028003 · DOI
  115. Stassen, 1993, Time course of improvement under antidepressant treatment: a survival-analytic approach, Eur Neuropsychopharmacol, 3, 127, 10.1016/0924-977X(93)90264-M · DOI
  116. Hirschfeld, 1997, The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression, JAMA, 277, 333, 10.1001/jama.1997.03540280071036 · DOI · Paper page
  117. Davis, 1995, Changing physician performance. A systematic review of the effect of continuing medical education strategies, JAMA, 274, 700, 10.1001/jama.1995.03530090032018 · DOI · Paper page
  118. Evans, 1986, Does a mailed continuing education program improve physician performance?, JAMA, 255, 501, 10.1001/jama.1986.03370040075027 · DOI
  119. Headrick, 1992, Efforts to improve compliance with the national Cholesterol Education Program guidelines, Arch Intern Med, 152, 2490, 10.1001/archinte.1992.00400240104017 · DOI
  120. Margolis, 1992, Computerized algorithms and pediatricians' management of common problems in a community clinic, Acad Med, 67, 282, 10.1097/00001888-199204000-00021 · DOI
  121. Anderson, 1994, Changing clinical practice: prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism, Arch Intern Med, 154, 669, 10.1001/archinte.1994.00420060103011 · DOI · Paper page
  122. Gemson, 1995, Putting prevention into practice: impact of a multifaceted physician education program on preventive services in the inner city, Arch Fam Med, 155, 2210
  123. Hunt, 1998, Effects of computer-based clinical decision support systems on physician performance and patient outcomes, JAMA, 280, 1339, 10.1001/jama.280.15.1339 · DOI · Paper page
  124. Francis, 1996, The Expert Consensus Guideline Series: treatment of schizophrenia, J Clin Psychiatry, 57, 1
  125. Francis, 1996, The Expert Consensus Guideline Series: treatment of bipolar disorder, J Clin Psychiatry, 57, 1
  126. Schoenbaum, 1990, Algorithm based improvement of clinical quality, BMJ, 301, 1374, 10.1136/bmj.301.6765.1374 · DOI
  127. Guiterrez, 1994, Changing physician prescribing patterns: evaluation of an educational strategy for acute diarrhea in Mexico City, Med Care, 32, 436, 10.1097/00005650-199405000-00003 · DOI
  128. Hristov, 1997, An active set algorithm for treatment planning optimization, Med Phys, 24, 1455, 10.1118/1.598034 · DOI
  129. Roland, 1995, A decision analysis of practice patterns used in evaluating and treating abnormal pap smears, Gynecol Oncol, 59, 75, 10.1006/gyno.1995.1270 · DOI
  130. Brennan, 1995, Developing policies and guidelines, Infect Control Hosp Epidemiol, 16, 512, 10.1086/647170 · DOI

Cited by

Metadata

Authors
Fava, M., Rush, A. J., Trivedi, M. H., Nierenberg, A. A., Thase, M. E., Sackeim, H. A., Quitkin, F. M., Wisniewski, S., Lavori, P. W., Rosenbaum, J. F., Kupfer, D. J., & for the STAR∗D Investigators Group
Venue
Psychiatric Clinics of North America
Publisher
Elsevier BV
Published
2003-06
Volume
26
Issue
2
Pages
457-494
ISSN
0193-953X (ISSN-L)
DOI
10.1016/s0193-953x(02)00107-7
OpenAlex
W2110341150
Cited by
519
References
18
FWCI
15.96
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.